"Therapeutic innovation in recent years has made it possible to meet the needs of our patients, but obviously, critical issues remain. These include access to referral centers dedicated to managing this disease, access that should be facilitated to impact not only patients' quality of life, but also the progression and natural history of the disease."
Nicola Scichilone, president-elect of the Italian Respiratory Society (SIP), stated this at the Longevitas Foundation meeting at the Ministry of Health Auditorium in Rome, dedicated to new models of adherence and sustainability of the National Health Service (NHS) in chronic respiratory diseases.
